Company · CIK 0001625288
NEXIEN BIOPHARMA, INC.
Exchange
—
Entity type
operating
Fiscal year end
Jun 30
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- 10-QQuarterly update0001641172-25-010067 · 2.9 MBSEC(opens sec.gov)
- 10-QQuarterly update0001493152-25-006734 · 2.9 MBSEC(opens sec.gov)
- 10-QQuarterly update0001493152-24-046468 · 2.8 MBSEC(opens sec.gov)
- 10-KAnnual report0001493152-24-041978 · 42.0 MBSEC(opens sec.gov)
- 10-QQuarterly update0001493152-24-019400 · 28.8 MBSEC(opens sec.gov)
- 10-QQuarterly update0001493152-24-007096 · 3.4 MBSEC(opens sec.gov)
- 10-QQuarterly update0001493152-23-041255 · 2.7 MBSEC(opens sec.gov)
- 10-KAnnual report0001493152-23-034480 · 4.0 MBSEC(opens sec.gov)
- 10-QQuarterly update0001493152-23-017925 · 3.0 MBSEC(opens sec.gov)
- 10-QQuarterly update0001493152-23-003903 · 3.0 MBSEC(opens sec.gov)
Insiders
- Aceto Joseph FVP Legal & IP Counsel
- Bankier Alain Dresigning officer & director
- Clark Courtney LynneDirector
- Friedland JeffreyFormer 10% Owner
- Goldfarb Robert IChief Operating Officer
- Greenberg Richard SDirector, Chief Executive Officer, 10% Owner
- Heiden IvoDirector, 10% Owner
- Kanativa Inc.10% Owner
- Kanativa USA Inc.10% Owner
- Manganella Frank JVP Corporate Development
Tickers
No tickers on record.
Addresses
business
4340 E KENTUCKY AVE SUITE 206
GLENDALE, CO, 80246
mailing
4340 E KENTUCKY AVE SUITE 206
GLENDALE, CO, 80246
Former names
- Intiva BioPharma Inc.2018-09-12
- Kinder Holding Corp.2017-11-06
Same industry